InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| R848 (Resiquimod) | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
| ODN 2216 - TLR9 ligand | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
| ODN 2006 (ODN 7909) | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
| CL413 VacciGrade™ | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
| Adilipoline™ (CL413) | Toll-like receptor dual-acting agonists are potent inducers of PBMC-produced ... | 2020 | Sci Rep. | Janovec V. et al. | DOI: 10.1038/s41598-020-69614-7 |
| CFA | Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. | 2020 | Sci Rep. | Dubé JY. et al. | DOI: 10.1038/s41598-020-62543-5 |
| EndoFit™ OVA protein | Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. | 2020 | Sci Rep. | Dubé JY. et al. | DOI: 10.1038/s41598-020-62543-5 |
| IFA | Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. | 2020 | Sci Rep. | Dubé JY. et al. | DOI: 10.1038/s41598-020-62543-5 |
| MDP | Synthetic mycobacterial molecular patterns partially complete Freund's adjuvant. | 2020 | Sci Rep. | Dubé JY. et al. | DOI: 10.1038/s41598-020-62543-5 |
| Anti-HLA Class I Control | A more efficient preparation system for HLA-eliminated platelets. | 2020 | Vox Sang. | Hayashi T et al. | DOI: 10.1111/vox.12859 |
| Anti-HLA Class II Control | A more efficient preparation system for HLA-eliminated platelets. | 2020 | Vox Sang. | Hayashi T et al. | DOI: 10.1111/vox.12859 |
| AddaVax™ | A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. | 2020 | Cell | Dai L. et al. | DOI: 10.1016/j.cell.2020.06.035. |
| R848 (Resiquimod) | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
| Zeocin® | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
| THP1-Dual™ KO-MyD88 Cells | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
| A549-Dual™ KO-RIG-I Cells | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
| 5'ppp-dsRNA | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
| A549-Dual™ Cells | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
| QUANTI-Blue™ | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |
| 3p-hpRNA - RIG-I agonist | Impact of mRNA chemistry and manufacturing process on innate immune activation. | 2020 | Sci Adv. | Nelson J. et al. | DOI: 10.1126/sciadv.aaz6893 |